ProShares Ultra Health Care
RXL
24 hedge funds and large institutions have $8.72M invested in ProShares Ultra Health Care in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
370% more call options, than puts
Call options by funds: $1.44M | Put options by funds: $306K
0.34% more ownership
Funds ownership: 7.04% → 7.38% (+0.34%)
8% less funds holding
Funds holding: 26 → 24 (-2)
21% less capital inflows, than outflows
Capital inflows: $2.69M | Capital outflows: $3.41M
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tower Research Capital (TRC)
New York
|
+$867K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$713K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$693K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$384K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$31.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$796K |
| 2 |
Advisor Group
Phoenix,
Arizona
|
-$791K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$574K |
| 4 |
Virtue Capital Management
Brentwood,
Tennessee
|
-$469K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$436K |
RXL Hedge Fund Activity: Q4 2018 in Review
24 of the 4,504 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q4 2018, worth a combined $8.72M — down 25% from $11.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RXL and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $867K. The largest seller was Jane Street, cutting an estimated $796K.
- 24 institutional investors held ProShares Ultra Health Care (RXL) as of Q4 2018, down from 26 in Q3 2018.
- Funds reported $8.72M of ProShares Ultra Health Care stock for Q4 2018, down 25% quarter-over-quarter.
- 3 funds opened new ProShares Ultra Health Care positions in Q4 2018 and 6 closed out, a net change of -3 holders.
- The largest ProShares Ultra Health Care buyer in Q4 2018 was Tower Research Capital (TRC), an estimated $867K added.
- The largest ProShares Ultra Health Care seller in Q4 2018 was Jane Street, an estimated $796K sold.
Based on aggregated 13F filings for Q4 2018.